Can we predict who will survive a hip fracture? new study tests 10 models
NCT ID NCT06961253
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study checks how well 10 existing prediction models can estimate the chance of dying within 30 days after a hip fracture. Researchers will look at data from 3500 patients in the Netherlands, using about 35 health factors. The goal is to find models that are accurate and useful for helping doctors and patients make informed decisions together.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors and patients make better decisions about care after a hip fracture by identifying those at highest risk.
What could go wrong
This is an observational study, not a treatment trial. The models may not perform well in real-world settings or may not improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIP FRACTURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
OLVG
Amsterdam, 1091AC, Netherlands